Jun 07, 2019
PTC Therapeutics Receives FDA Approval for the Expansion of the EMFLAZA® (deflazacort) Labeling to Include Patients 2-5 Years of Age
Jun 04, 2019
Parent Project Muscular Dystrophy Awards $175,000 Grant to UCLA to Explore Optimization of CRISPR Technology in Duchenne Muscular Dystrophy
Apr 18, 2019
Parent Project Muscular Dystrophy Awards $100,000 Grant to Nationwide Children's Hospital to Further Explore GALGT2 Gene Therapy in Duchenne Muscular Dystrophy
Feb 13, 2019
PTC Therapeutics Launches Fifth Annual STRIVE Grant Award Program for Duchenne Muscular Dystrophy
Feb 11, 2019
Parent Project Muscular Dystrophy Designates University of Rochester Medical Center as a Certified Duchenne Care Center
Jan 31, 2019
PTC Therapeutics Launches New Program to Support Research Projects in Rare, Genetic Disorders
Jan 29, 2019
Parent Project Muscular Dystrophy Designates Children's Hospital of The King's Daughters as a Certified Duchenne Care Center
Jan 17, 2019
Parent Project Muscular Dystrophy Publishes 10 Year Registry Report
Dec 19, 2018
Parent Project Muscular Dystrophy Awards $329,000 Grant to Binghamton University to Examine the Role of the Immune System on Dystrophin Restoration
Dec 13, 2018
Parent Project Muscular Dystrophy Announces Partnership with THREAD to Enhance Current Duchenne Registry Platform
Nov 13, 2018
Evox Therapeutics Wins Funding From Duchenne UK to Explore Exosome-Mediated Delivery of Dystrophin
Nov 06, 2018
Parent Project Muscular Dystrophy Designates Children's Hospital of Wisconsin a Certified Duchenne Care Center
Nov 01, 2018
Parent Project Muscular Dystrophy Designates Children's National Health System, a Certified Duchenne Care Center
Oct 06, 2018
PTC Therapeutics Announces Initial Data from Patient Registry Demonstrating Translarna(TM) (ataluren) Slows Disease Progression in Children with Duchenne Caused by a Nonsense Mutation
Sep 27, 2018
Miles for Matthew Marks 10-Year Anniversary
Sep 07, 2018
PTC Therapeutics Announces Winners of Global Duchenne Muscular Dystrophy Patient Group STRIVE Awards in Recognition of World Duchenne Awareness Day
Sep 07, 2018
Parent Project Muscular Dystrophy and Sarepta Therapeutics Partner to Launch Duchenne Outcomes Research Interchange, a Patient-Data Warehouse Serving the Entire Duchenne Community
Sep 05, 2018
Parent Project Muscular Dystrophy Designates American Family Children's Hospital, a Certified Duchenne Care Center
Aug 02, 2018
First Patient Enrolled in Mallinckrodt's Phase 2 Duchenne Muscular Dystrophy Trial
Jun 27, 2018
Parent Project Muscular Dystrophy to Host Annual Conference in Scottsdale, Arizona